FREDERICK MCINTYRE: Open Payments
NPI 1932200656 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,113 in 124 payments from 26 companies in 2025. Trend: 2023 $3,035 · 2024 $2,200 · 2025 $2,113
Food & beverage: $2,113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $472 |
| PFIZER INC. | 15 | $250 |
| Novo Nordisk Inc | 13 | $196 |
| AstraZeneca Pharmaceuticals LP | 8 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $169 |
| Lilly USA, LLC | 6 | $125 |
| Astellas Pharma US Inc | 3 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $51 |
Products named: VRAYLAR, NURTEC ODT, XIFAXAN, Ozempic, FARXIGA, QULIPTA, UBRELVY, REXULTI.
Industry payments across NC — which companies pay providers there.
